News and Comments

SAREPTA: What's Going On ?

  Tuesday, April 16, 2013

The requests Sarepta Therapeutics (SRPT) has gotten from the FDA represent a sign of FDA seriousness towards bringing the firm’s drug eteplirsen for Duchenne muscular dystrophy as soon as possible to the children suffering from the debilitating, fast deteriorating disease. The FDA did not wait for the firm to file for early approval, it rather asked Sarepta to bring in more data that would legitimize granting early approval of the first drug ever to claim treating the disabling disease at its root-origin. Investors who should have been optimistic about the FDA initiative sold their shares instead, causing them to lose around 10% of their value.  More...

ImmunoGen Offers New Hopes For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Difficult-To-Treat Cancers

  Friday, April 12, 2013


A Quick Response To ARIAD'S (ARIA) Conference Call

  Thursday, April 04, 2013


Recent Postings



Array Pharmaceuticals (ARRY) Anadys (ANDS) Incyte (INCY) Abbott Laboratories (ABT) Sanofi-Aventis (SAN) Vertex (VRTX) Dendreon (DNDN) ADVENTRIX (ANX) Theravance (THRX) Gilead (GILD) Multiple Myeloma Human Genome Sciences (HGSI) Ridaforolimus SUNESIS PHARMACEUTICALS (SNSS) Cytokinetics (CYTK) Bristol-Myers Squibb (BMY) Biogen Idec (BIIB) Benlysta (belimumab) Rapamune Pluristem (PSTI) Mirati Therapeutics (MRTX) Prosensa (RNA) Inovio (INO) Onyx (ONXX) Sanofi (SNA) Genentech Sangamo (SGMO) NEKTAR (NKTR)) Prolor Biotech (PBTH) ARCA (ABIO) Velcade (bortezomib) Telaprevir Auspex (ASPX) VANDA (VNDA) Valeant Pharmaceuticals International (VRX) Exelixis (EXEL) ISIS (ISIS) Ziofpharm (ZIOP) Intermune (ITMN) Amgen (AMGN) Illumina (ILMN) SYNTA (SNTA) Idenix (IDIX) SERES THERAPEUTICS (MCRB) ABBVIE (ABBV) BIOMARIN (BMRN) Alnylam (ALNY) HALOZYME (HALO) Roche (RHHBY) Dynavax (DVAX) Intrexon (XON) Sanofi (SNY) KITE (KITE) Herceptin Revlimid (lenolidamide) Sarepta (SRPT) ImmunoGen (IMGN) Galena (GALE) KERYX (KERX) Agenus (AGEN galapagos (GLPG) Agenus (AGEN) Elan (ELN) JUNO (JUNO) Endometrial Cancer Intercept (ICPT) NANTKWEST (NK) Trastuzumab-DM1 Seattle Genetics (SGEN) OSI (OSIP) AERIE PHARMACEUTICALS C4 Therapeutics Anacor (ANAC) Aimmune Therapeutics (AIMT) GUARDIAN HEALTH ZALTRAP™ Sequenom (SQNM) TOKAI (TKAOI) CompuGen (CGEN) Jazz Pharmaceuticals (JAZZ) Micromet (MITI) IDERA (IDRA) Biocryst (BCRX) Xoma (XOMA) Tysabri Merck (MRK) Roche (ROCHE) Zerenex GlaxoSmithKline (GSK) Ariad (ARIA) Regeneron (REGN)